NATRIXAM

This brand name is authorized in Croatia, Estonia, France, Hong Kong SAR China, Lithuania, Malta, Netherlands, Nigeria, Romania, Singapore, Tunisia, Turkey.

Active ingredients

The drug NATRIXAM contains a combination of these active pharmaceutical ingredients (APIs):

1	Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE
	Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.
	Read more about Amlodipine
2	Indapamide UNII F089I0511L - INDAPAMIDE
	Indapamide is a sulfonamide derivative with an indole ring, pharmacologically related to thiazide diuretics, which acts by inhibiting the reabsorption of sodium in the cortical dilution segment. It increases the urinary excretion of sodium and chlorides and, to a lesser extent, the excretion of potassium and magnesium, thereby increasing urine output and having an antihypertensive action.
	Read more about Indapamide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NATRIXAM Modified-release tablet	MPI, EU: SmPC	Web Search

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C08GA02		C Cardiovascular system → C08 Calcium channel blockers → C08G Calcium channel blockers and diuretics → C08GA Calcium channel blockers and diuretics
Discover more medicines within C08GA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1588169, 1588170, 1588181, 1588192, 1588204, 1588215, 1588226, 1588237, 1588248, 1588259, 1588260, 1588271
FR	Base de données publique des médicaments	66660014, 67290596
HK	Department of Health Drug Office	65206, 65207
HR	Agencija za lijekove i medicinske proizvode	HR-H-053397374, HR-H-921621992
LT	Valstybinė vaistų kontrolės tarnyba	1066883, 1066884, 1066885, 1066886, 1071906, 1071907, 1071908, 1071909, 1071910, 1071911, 1071912, 1071913, 1091876, 1091877, 1091878, 1091879
MT	Medicines Authority	MA066/02101, MA066/02102
NG	Registered Drug Product Database	B4-4152, B4-4153
Switch country to Nigeria in order to find specific presentations of NATRIXAM
NL	Z-Index G-Standaard, PRK	113492, 113506
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W60529001, W60529002, W60529003, W60529004, W60529005, W60529006, W60530001, W60530002, W60530003, W60530004, W60530005, W60530006
SG	Health Sciences Authority	14901P, 14902P
TN	Direction de la Pharmacie et du Médicament	6353181, 6353182
TR	İlaç ve Tıbbi Cihaz Kurumu	8699552030102, 8699552030119